Abstract
Objectives: Standard treatments of adductor spasmodic dysphonia (AdSD) provide temporary relief of symptoms. Type 2 thyroplasty offers a long‐term solution; however, long‐term voice outcome data are lacking. The objective of this study was to assess the long‐term voice outcomes of type 2 thyroplasty with titanium bridges through use of a validated voice questionnaire.Study Design: Case series with chart review.Setting: University hospital.Subjects and Methods: Forty‐seven consecutively enrolled patients with AdSD underwent type 2 thyroplasty with titanium bridges between August 2006 and November 2014. Questionnaires were completed during regularly scheduled follow‐ups and, in some cases, were sent to patients who missed follow‐up appointments. In 2015, questionnaires were mailed to all 47 patients and included a Voice Handicap Index–10 evaluation, as well as questions on postoperative vocal symptoms, surgical site, and status of the implanted titanium bridges.Results: Of 47 patients with AdSD, 31 (66%) completed the questionnaires. The average follow‐up interval was 41.3 months. No patient reported experiencing an adverse event around the surgical site, and almost all were satisfied with their voices postoperatively. The mean postoperative (>3 years) Voice Handicap Index–10 score improved significantly, from 26.3 to 9.4 (n = 17, P =. 0009).Conclusions: Type 2 thyroplasty for AdSD significantly improved patient quality of life and voice symptoms and continued to do so long after the surgery. The results of this study suggest that type 2 thyroplasty provides relief from vocal symptoms in patients with AdSD for >3 years.
Funding Information
  • Japan Agency for Medical Research and Development

This publication has 17 references indexed in Scilit: